Flow cytometry dataset

Figure 1C-D, flow cytometry analysis of PCs (OVA+ B220low CD138+) from mice draining lymph nodes and spleen at 3 weeks after i.m. immunization with OVA; Figure 1G-H, flow cytometry analysis of GC B cells (B220+ GL7+ Fas+) and Tfh cells (B220- CD3+ CD4+ CD44hi CXCR5+PD-1+) on day 10 after immunization with OVA; Figure 2H,mean fluorescence intensity (MFI) of CD86 on FO B cells from mice lymph nodes of mice 10 days post-immunization with OVA; Figure 2J, flow cytometry analysis of IgG1 expression in activated murine B cells treated with the Beraprost or Beraprost and H89, under stimulation with LPS plus IL-4; Figure 4F-G, flow cytometry analysis of RABV-specific specific PCs and RABV-specific MBCs in human PBMCs 13 days after the first shot vaccination.

图1C-D为卵清蛋白（Ovalbumin, OVA）肌内（intramuscular, i.m.）免疫后3周，小鼠引流淋巴结与脾脏中浆细胞（Plasma Cells, PCs，表型为OVA+ B220low CD138+）的流式细胞术分析结果；图1G-H为OVA免疫后第10天，小鼠生发中心B细胞（Germinal Center B Cells, GC B cells，表型为B220+ GL7+ Fas+）与滤泡辅助T细胞（Follicular Helper T Cells, Tfh cells，表型为B220- CD3+ CD4+ CD44hi CXCR5+PD-1+）的流式细胞术分析结果；图2H为OVA免疫后10天，小鼠淋巴结滤泡型B细胞（Follicular B Cells, FO B cells）表面分化簇86（CD86）的平均荧光强度（Mean Fluorescence Intensity, MFI）检测结果；图2J为脂多糖（Lipopolysaccharide, LPS）联合白细胞介素4（Interleukin 4, IL-4）刺激条件下，经贝拉前列素（Beraprost）或贝拉前列素联合H89处理的活化小鼠B细胞中免疫球蛋白G1（IgG1）表达的流式细胞术分析结果；图4F-G为首次疫苗接种后13天，人外周血单个核细胞（Peripheral Blood Mononuclear Cells, PBMCs）中狂犬病病毒（Rabies Virus, RABV）特异性浆细胞与狂犬病病毒特异性记忆B细胞（Memory B Cells, MBCs）的流式细胞术分析结果。